Bristol-myers Squibb Compnay

Astrazeneca Ab

Bristol-myers Squibb Holdings Ireland

Dilbir S Bindra

Prakash V Parab

Gretchen M Schroeder

Mandar V Dali

Victor W Rosso

Ravindra W Tejwani

Jatin M Patel

Yongmei Wu

Nipa Vatsaraj

Li Tao

Ajit B Thakur

Sherif Ibrahim Farag Badawy

Cletus John Nunes

Madhushree Yeshwant Gokhale

Venkatramana M Rao

Yongemei Wu

Robert Kevin Perrone

Preetanshu Pandey

Rhye Hamey

Chandra Vemavarapu

Keirnan Ryan Lamarche

Ajit S Narang

Ganeshkumar A Subramanian

Disclosed are salts and crystalline forms of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide and salts thereof. Also disclosed are at least one pharmaceutical composition comprising at least one crystalline form of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide, at least one method of using at least one crystalline form of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide to treat cancer and/or other proliferative diseases, and processes to prepare crystalline forms of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide and salts thereof.

Pharmaceutical compositions comprising N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate and a pharmaceutical acceptable carrier therefor, which formulation is designed for immediate release.

Pharmaceutical formulations containing an SGLT2 inhibitor

Pharmaceutical compositions comprising N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-OXO-1,2-dihydropyridine-3-carboxamide

Growing community of inventors

New Brunswick, NJ, United States of America

Dilbir S Bindra